India, April 7 -- A comprehensive new study led by the University of Southampton has found that medications used to treat attention deficit hyperactivity disorder (ADHD) have only minor effects on cardiovascular health over several weeks or months of use.
Published in The Lancet Psychiatry, the study is the most extensive analysis of its kind, examining the cardiovascular effects of ADHD drugs through randomized controlled trials or RCTs.
Professor Samuele Cortese, senior lead author from the University of Southampton, said the findings provide reassurance adding that the risks and benefits of taking any medication had to be assessed together, but for ADHD drugs the risk-benefit ratio was "reassuring".
"We found an overall small increase...